Enfermedades Neurológicas

Caronna, E; Mas-de-les-Valls, R; Egeo, G; Vázquez, MM; Nieves-Castellanos, C; Portocarrero-Sánchez, L; Vaghi, G; Rodríguez-Montolio, J; Jaimes, A; Muñoz-Vendrell, A; Oliveira, R; Polanco, M; Osorio, YG; Canales, J; Ornello, R; Thunstedt, C; Fernández-Lázaro, I; Husoy, A; Sánchez-Soblechero, A; Vicente, BN; Riesco, N; Pina, BF; Fernandes, C; Lopez, AA; Martins-Silva, E; Budrewicz, S; Gallardo, VJ; Dabó, LG; Torres-Ferrus, M; Alpuente, A; Torelli, P; Aurilia, C; Lamas, R; Castrillo, MJR; De Icco, R; Sances, G; Broadhurst, S; Winstanley, J; Gómez, A; Campoy, S; Marques, I; Parreira, E; Gárate, G; Pascual, J; Peral, ALG; Caponnetto, V; Straube, A; Gonzalez-Martinez, A; Quintas, S; Sánchez-del-Río, M; Tronvik, E; Pérez, BV; Duran, AO; Rodrigues, M; Cevoli, S; Colombo, B; Trimboli, M; Frediani, F; d'Onofrio, F; Aguggia, M; Salerno, A; Carnevale, A; Zucco, M; Albanese, M; Finocchi, C; Ranieri, A; Zoroddu, F; Autunno, M; Sanahuja, J; Waliszewska-Prosól, M; Pereira, L; Layos-Romero, A; Luzeiro, I; Dorado, L; Alvarez-Escudero, R; Martins, IP; Sundal, C; Irimia, P; Ros, AL; Gago-Veiga, AB; Juanes, FV; Ruscheweyh, R; Sacco, S; García-Azorín, D; González-Quintanilla, V; Gil-Gouveia, RS; Villanueva, MH; Rodríguez-Vico, J; Lasaosa, SS; Ghadri-Sani, M; Tassorelli, C; Velasco, FJDD; Diaz-Insa, S; Oria, CG; Barbanti, P; Pozo-Rosich, P.

Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort

NEUROLOGY. 2026; 106(4): [doi:10.1212/WNL.0000000000214659]

Mateo-Sierra, O; Pérez-Sánchez, JR; De la Casa-Fages, B; Del Castillo, MT; Fernández, P; Elvira, P; Paz, J; Grandas, F.

Symptom-Oriented, Connectome-Informed Deep Brain Stimulation for Asymmetric Dystonic Tremor: Unilateral Ventral Intermediate Nucleus (VIM) DBS Targeting a Tremor-Dominant Network

Journal of Clinical Medicine. 2026; 15(4): [doi:10.3390/jcm15041666]

Alungulese, AL; Alvarez, IC; Arredondo, IM; Sala, PR; Arias, F; Montalvo, JP; Rodriguez, MIE.

Acquired multiple acyl-CoA dehydrogenase deficiency (MADD) provoked by sertraline: an emerging and treatable disorder

Practical Neurology. 2026; : [doi:10.1136/pn-2025-005016]

Quiroz, V; Alecu, JE; Zubair, U; Bernardi, K; Zaman, Z; Rong, J; Tam, A; Kunta, A; Agianda, HAP; Battaglia, N; Schmidt, HJD; Resch, D; Wyman, N; Vogt, LM; Uraba, WB; Becker, LF; Kothur, K; Gill, D; Suarez, B; Jofre, J; Arias, C; Castiglioni, C; Möller, PDD; Duarte, AFP; Eggers-Lisboa, A; Ríos-Pohl, L; Gonzalez-Ubilla, M; Chaudhari, C; Salazar-Villacorta, A; Tian, XJ; Dai, LF; Ding, CH; Zamani, M; Nourbakhsh, P; Shariati, G; Pringsheim, T; Lim, WK; Bartolini, E; Stamelou, M; Bhatia, P; Kruer, MC; Desai, S; Iype, M; Necpál, J; Crosiers, D; Jones, HF; Perez-Sanchez, JR; Unal, ED; Lopez-Ariztegui, N; Kola, S; Lin, WS; Mansour, AH; Triki, CC; Fernandez-Alvarez, E; Roze, E; Sahu, JK; Doja, A; Nardocci, N; Caputo, D; Koy, A; Bhate, S; Kaliakatsos, M; Robinson, R; Hassell, J; Pons, R; Munchau, A; Soliani, L; Zea-Vera, A; Tochen, L; Morales-Briceño, H; Dale, RC; D'Gama, A; Loddenkemper, T; Pearl, PL; Mohammad, SS; Kurian, MA; Gorodetsky, C; Ortigoza-Escobar, JD; Schierbaum, L; Yang, K; Ebrahimi-Fakhari, D.

Molecular and clinical spectrum of epilepsy-dyskinesia syndromes: a cross-sectional study of 609 patients

BRAIN. 2026; 149(2): 563-578 Nº de citas: 2 [doi:10.1093/brain/awaf297]

Villanueva, V; Serratosa, JM; Fernández-Cabrera, A; Toledo, M; González-Giráldez, B; Estevez, JC; Uranga, JJR; Castelló, MM; Castro-Vilanova, MD; Poza, JJ; Rodríguez-Osorio, X; Hampel, KG; Fonseca, E; López-González, FJ; Garcés, M; Abraira, L; Ciurans, J; Campos-Fernández, D; Santamarina, E; Sanchez-Caro, JM; Iacampo, L; Renau, J; García-Quesada, MA; Anciones, C; Chamorro, MI; Maestro, I; Cabezudo, P; Calle, R; Macarron, J; Cabezas, B; Carrasco, M; López, M; Marín, M; Querol, R; Baena, B; García-Morales, V; López-Maza, S; Juiz, A; Mercedes-Alvarez, B; Amarante, C; Del Villar, A; Castillo, A; Rubio-Roy, M; Martinez-Poles, J; Gómez-Ibáñez, A; Parejo-Carbonell, B; Garcia, AM; Carrera, I; Iriarte, P; Romero-Aguilera, F.

Freedon study: Real-life outcomes of cenobamate in different lines of treatment

EPILEPSIA. 2026; : [doi:10.1002/epi.70106]

García-Leal, R; Prieto-Montalvo, J; De Villoria, JG; Zanin, M; Rausell, E.

Functional Connectivity Between Human Motor and Somatosensory Areas During a Multifinger Tapping Task: A Proof-of-Concept Study

Neurosci. 2026; 7(1): [doi:10.3390/neurosci7010012]

Mateo-Sierra, O; De la Casa-Fages, B; Martín-Ramírez, E; Barreiro-Gómez, M; Grandas, F.

Deep Brain Stimulation as a Rehabilitation Amplifier: A Precision-Oriented, Network-Guided Framework for Functional Restoration in Movement Disorders

Journal of Clinical Medicine. 2026; 15(2): [doi:10.3390/jcm15020492]

Indelicato, E; Carmona-Hidalgo, B; Quintero, J; Escobar, JDO; Koy, A; Salamon, A; Tacik, P; Muñoz-Delgado, L; Giannini, G; Reich, M; Albanese, A; Bäumer, T; Grandas, F; Jech, R; Leonardos, A; Mir, P; Pérez-Dueñas, B; Perez-Sanchez, JR; Valldeoriola, F; Zanni, G; Vidailhet, M; Rodríguez-López, R; Blasco-Amaro, JA; Reinhard, C; Boesch, S.

Efficacy of Deep Brain Stimulation for the Treatment of Monogenic Dystonia Symptoms: A Systematic Review

EUROPEAN JOURNAL OF NEUROLOGY. 2026; 33(1): Nº de citas: 1 [doi:10.1111/ene.70490]

Salgado-Cámara, P; De la Casa-Fages, B; Sánchez-Soblechero, A; Sierra, OM; Martín-Barbero, ML; Grandas, F.

Impact of a perioperative protocol for Parkinson's disease patients on use of contraindicated drugs

NEUROLOGIA. 2026; 41(1): [doi:10.1016/j.nrl.2023.11.011]

López-Delgado, IE; Navarro-López, V; Grandas-Pérez, F; Godino-Llorente, JI; Grajal, J.

Radar Network for Gait Monitoring: Technology and Validation

IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING. 2026; 73(1): 393-403 [doi:10.1109/TBME.2025.3583785]

Ryvlin, P; Huot, M; Valton, L; Maillard, L; Bartolomei, F; Derambure, P; Hirsch, E; Chassoux, F; Crespel, A; Biraben, A; Navarro, V; Kahane, P; De Toffol, B; Thomas, P; Rosenberg, S; Bernini, A; Charlois, AL; Craciun, L; Chorfa, F; Ducouret, P; Ferreira, A; Leclercq, M; Marty, M; Alvarez, BM; Sampaio, M; Spahr, A; Timestit-Kurland, N; Touya, M; Roy, P; Rheims, S.

Seizure-related biomarkers of sudden unexpected death in epilepsy (SUDEP) in drug-resistant focal epilepsy (REPO2MSE): a prospective, multicentre case-control study

LANCET NEUROLOGY. 2026; 25(1): 50-60 Nº de citas: 3 [doi:10.1016/S1474-4422(25)00379-5]

Català, I; Rolán, H; Fernández-Carballal, C; Domínguez-Alonso, C; Alvarez-Galovich, L; Godino, O.

A new hernia blocking system prevents lumbar disc herniation recurrence and disc degeneration: 2 years results of a multicentric clinical investigation

Brain And Spine. 2026; 6: 105898-105898 Nº de citas: 1 [doi:10.1016/j.bas.2025.105898]

Montero-Pardo, C; Rocon, E; Dosen, S; Dideriksen, JL; Gutiérrez, A; Pérez-Sánchez, JR; Luque-Buzo, E; Louis, ED; Grandas, F; Oliveira-Barroso, F.

Emerging Noninvasive Approaches for the Suppression of Pathological Tremor

IEEE Reviews in Biomedical Engineering. 2025; 19: 65-85 [doi:10.1109/RBME.2025.3639754]

Rodero-Romero, A; Domínguez-Mozo, M; Monreal, E; García-Domínguez, JM; Villarrubia, N; Fernández-Velasco, JI; Comabella, M; de la Maza, SS; Briceño, HG; Chico-García, JL; García-Martínez, MA; Rodriguez-Jorge, F; Veiga-Gonzalez, JL; Sainz-Amo, R; Ginés, MLM; Montalban, X; Masjuan, J; Costa-Frossard, L; Alvarez-Lafuente, R; Villar, LM.

New serum soluble factors predicting inflammatory and non-inflammatory disability worsening in multiple sclerosis

Frontiers in Immunology. 2025; 16: Nº de citas: 1 [doi:10.3389/fimmu.2025.1729500]

Muñoz-Vendrell, A; Campoy-Díaz, S; Valín-Villanueva, P; Casas-Limón, J; Fernández-Lázaro, I; González-García, N; Santos-Lasaosa, S; Osorio, YG; Gonzalez-Martinez, A; Campdelacreu, J; Portocarrero-Sánchez, L; Sánchez, LMC; Sánchez, SMG; Pérez-de-la-parte, A; Sánchez-Mateos, NM; López-Bravo, A; Mínguez-Olaondo, A; Sánchez-Soblechero, A; Ros, AL; Hernández, CM; López, AA; Layos-Romero, A; Caronna, E; Torres-Ferrús, M; Alpuente, A; Pozo-Rosich, P; Belvís, R; Garcia-Azorin, D; Díaz-de-Terán, J; Guerrero-Peral, AL; Gago-Veiga, AB; Huerta-Villanueva, M.

Atogepant after anti-CGRP monoclonal antibodies failure in migraine: a multicenter real-world study of effectiveness, safety, persistence and predictors of response

JOURNAL OF HEADACHE AND PAIN. 2025; 27(1): Nº de citas: 1 [doi:10.1186/s10194-025-02239-1]

Sanabria-Gago, C; Lázaro, IF; Heredia, P; Sánchez-Soblechero, A; Ros, AL; Buzo, EL; Osorio, YG; Guerrero-Peral, A; Gonzalez-Martinez, A; Azorín, DG; Latorre, G; Calle, C; Toledo-Alfocea, D; Limon, JC; Valle, SU; Salaices, MG; Avila, GM; Carpio, RT; Pascual, J; González-Quintanilla, V; Madera, J; Polanco, M; Rodríguez-Vico, J; Jaimes, A; García, AG; Cuadrado, ML; Gago-Veiga, AB.

SAFE-CGRP study: multicenter retrospective evaluation of the safety of CGRP pathway-targeting monoclonal antibodies in migraine with relevant comorbidities or conditions excluded from trials

Frontiers in Neurology. 2025; 16: [doi:10.3389/fneur.2025.1703876]

Faggioli, G; Menotti, L; Marchesin, S; Trescato, I; Ahmad, L; Aidos, H; Alungulese, AL; Bellazzi, R; Bergamaschi, R; Birolo, G; Bosoni, P; Cabrera-Umpiérrez, MF; Cavalla, P; Chio, A; Dagliati, A; De Carvalho, M; Fariselli, P; Dominguez, JMG; Martínez, SG; Gromicho, M; Guazzo, A; Jovanovic, A; Kostic, B; Longato, E; Madeira, SC; Manera, U; Blanco, JLM; Tavazzi, E; Tavazzi, E; Iglesias, ET; Urosevic, V; Vettoretti, M; Di Nunzio, GM; Silvello, G; Di Camillo, B; Ferro, N.

The BRAINTEASER Datasets: Clinical, Wearable and Environmental Data for ALS & MS Progression Modeling

Scientific Data. 2025; 12(1): Nº de citas: 1 [doi:10.1038/s41597-025-06095-1]

Mateo-Sierra, O; Romero-Cumbreras, E; García-Llorente, E; Rubín-Alduán, S.

From Crisis Response to Lasting Transformation: Five-Year Insights from the Implementation of Telemedicine in Neurosurgical Care During COVID-19

Healthcare. 2025; 13(22): [doi:10.3390/healthcare13222939]